The genetic screening of embryos for a wider range of diseases, including breast, ovarian and colon cancers, has been approved by the UK’s fertility authority.

Until recently, the Human Fertilisation and Embryology Authority (HFEA) only permitted tests for diseases that cause severe disability or death in childhood and have a 100% certainty of being inherited, such as cystic fibrosis.